(Q46833575)

English

Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia

scientific article published in December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

medroxyprogesterone acetate

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Anne Beate Vereide

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

Turid Kaino

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

Georg Sager

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

Marit Arnes

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

Anne Ørbo

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

language of work or name

0 references

publication date

1 December 2005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

Gynecologic Oncology

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

101

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

214-223

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

Progestin regulation of cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Physiological action of progesterone in target tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Molecular mechanisms of action of steroid/thyroid receptor superfamily members

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Progesterone receptors in reproduction: functional impact of the A and B isoforms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Prognostic significance of hormone receptors in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Immunohistochemical assay for oestrogen receptors in paraffin wax sections of breast carcinoma using a new monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Progesterone antagonism of the oestrogen receptor and oestrogen-induced uterine growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Control of Uterine Estrogen Receptor Levels by Progesterone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Effects of progestins on estradiol receptor levels in human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Estrogen receptors: bioactivities and interactions with cell signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Regulation of signal transduction pathways by estrogen and progesterone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Making Sense of Cross-Talk between Steroid Hormone Receptors and Intracellular Signaling Pathways: Who Will Have the Last Word?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Progesterone and dexamethasone inhibition of uterine epithelial proliferation in two models of estrogen-independent growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Non-genomic effects of progestins--inhibition of cell growth and increased intracellular levels of cyclic nucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Nongenomic actions of steroid hormones in reproductive tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Non-genomic actions of sex steroid hormones.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.030

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.10.030

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16325240

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46833575&oldid=2134009385"